| IFI | Invasive fungal infection |
| HSCT | Hematopoietic stem cell transplantation |
| IC | Invasive candidemia |
| IA | Invasive aspergillosis |
| bIFI | Breakthrough invasive fungal infection |
| GVHD | Graft-versus-host disease |
| CMV | Cytomegalovirus |
| DDI | Drug–drug interaction |
| GM | Galactomannan |
| CT | Computed tomography |
| RCT | Randomized clinical trials |
| AML | Acute myeloid leukemia |
| MDS | Myelodysplastic syndrome |
| EORTC/MSG-ERC | European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium |
| GI | Gastrointestinal |
| MDR | Multidrug-resistant |
| AST | Antifungal susceptibility testing |
| TDM | Therapeutic drug monitoring |
| L-AmB | Liposomal amphotericin B |
| BAL | Bronchoalveolar lavage |
| mNGS | Metagenomic next-generation sequencing |